Try our Advanced Search for more refined results
June 05, 2013
AbbVie Inc. et al v. Dr. Reddy's Laboratories Ltd. et al
Case Number:
1:13-cv-01012
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
June 06, 2013
AbbVie Hits Dr. Reddy's With IP Suit Over Generic Zemplar
Pharmaceuticals maker AbbVie Inc. on Wednesday accused Dr. Reddy's Research Laboratories Ltd. of infringing three drug patents by seeking approval for a generic version of the hyperactive-thyroid medication Zemplar, according to a suit filed in Delaware federal court.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login